{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:10:51Z","timestamp":1794287451020,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019484","name":"Merit Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Corticosteroid injections are commonly used to treat symptomatic knee osteoarthritis; however, pain relief is usually transient. Genicular artery embolization (GAE) has shown promise as an effective minimally invasive intervention to alleviate symptomatic knee osteoarthritis. The MOTION study is being conducted to compare outcomes following GAE versus corticosteroid injection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>This is an international, multicenter, randomized controlled investigational device exemption (IDE) study enrolling adults (\u2265\u200921 years old) with symptomatic knee osteoarthritis (Kellgren\u2013Lawrence grades 1\u20134) across \u2265\u200945 centers worldwide. Patients will be randomized 1:1 to receive GAE with Embosphere\u00ae Microspheres (Merit Medical Systems, Inc.) or corticosteroid injections. The primary efficacy measure is clinical success at 6 months, defined as \u2265\u200950% improvement in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale. The primary safety measure is the proportion of patients free from treatment-related safety event(s) through 6-month post-index procedure (GAE or corticosteroid injection). Following the 6-month visit, patients in either cohort who do not achieve clinical success may crossover to the other study arm. Additional study measures will assess safety and efficacy outcomes throughout the 24-month follow-up period. The target sample size is 264 (132 per arm) and is based on the number of patients needed to confirm superior efficacy of GAE versus corticosteroid injections and non-inferiority with respect to safety. The overall study power is &gt;\u200980%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Findings from the MOTION study are expected to provide information on the magnitude of the therapeutic benefits associated with GAE versus standard of care over 24 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial Registration<\/jats:title>\n            <jats:p>NCT05818150.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00270-025-03994-z","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T18:04:04Z","timestamp":1741284244000},"page":"551-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multicenter, PrOspective, Randomized, Controlled Trial Comparing GenIcular Artery EmbOlization Using Embosphere Microspheres to Corticosteroid iNjections for the Treatment of Symptomatic Knee Osteoarthritis: MOTION Study Protocol Summary"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-2694","authenticated-orcid":false,"given":"Clare","family":"Bent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"McAsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Bagla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"3994_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7812\/TPP\/16-183","volume":"21","author":"MJ Lespasio","year":"2017","unstructured":"Lespasio MJ, Piuzzi NS, Husni ME, Muschler GF, Guarino A, Mont MA. Knee osteoarthritis: a primer. Perm J. 2017;21:16\u2013183. https:\/\/doi.org\/10.7812\/TPP\/16-183.","journal-title":"Perm J"},{"issue":"12","key":"3994_CR2","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/acr.25158","volume":"75","author":"G Yang","year":"2023","unstructured":"Yang G, Wang J, Liu Y, et al. Burden of knee osteoarthritis in 204 countries and territories, 1990\u20132019: results from the global burden of disease study 2019. Arthritis Care Res (Hoboken). 2023;75(12):2489\u2013500. https:\/\/doi.org\/10.1002\/acr.25158.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3994_CR3","doi-asserted-by":"publisher","first-page":"100587","DOI":"10.1016\/j.eclinm.2020.100587","volume":"29\u201330","author":"A Cui","year":"2020","unstructured":"Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020;29\u201330:100587. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100587.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"3994_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12891-022-05306-9","volume":"23","author":"M Hardenberg","year":"2022","unstructured":"Hardenberg M, Spekle EM, Coenen P, Brus IM, Kuijer P. The economic burden of knee and hip osteoarthritis: absenteeism and costs in the Dutch workforce. BMC Musculoskelet Disord. 2022;23(1):364. https:\/\/doi.org\/10.1186\/s12891-022-05306-9.","journal-title":"BMC Musculoskelet Disord"},{"key":"3994_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/CEOR.S302289","volume":"13","author":"AV Bedenbaugh","year":"2021","unstructured":"Bedenbaugh AV, Bonafede M, Marchlewicz EH, Lee V, Tambiah J. Real-world health care resource utilization and costs among US patients with knee osteoarthritis compared with controls. Clinicoecon Outcomes Res. 2021;13:421\u201335. https:\/\/doi.org\/10.2147\/CEOR.S302289.","journal-title":"Clinicoecon Outcomes Res"},{"key":"3994_CR6","doi-asserted-by":"publisher","first-page":"698709","DOI":"10.1155\/2012\/698709","volume":"2012","author":"A Chen","year":"2012","unstructured":"Chen A, Gupte C, Akhtar K, Smith P, Cobb J. The global economic cost of osteoarthritis: how the UK compares. Arthritis. 2012;2012:698709. https:\/\/doi.org\/10.1155\/2012\/698709.","journal-title":"Arthritis"},{"issue":"3","key":"3994_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5312\/wjo.v13.i3.212","volume":"13","author":"WB Lim","year":"2022","unstructured":"Lim WB, Al-Dadah O. Conservative treatment of knee osteoarthritis: a review of the literature. World J Orthop. 2022;13(3):212\u201329. https:\/\/doi.org\/10.5312\/wjo.v13.i3.212.","journal-title":"World J Orthop"},{"issue":"19","key":"3994_CR8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2017.5283","volume":"317","author":"TE McAlindon","year":"2017","unstructured":"McAlindon TE, LaValley MP, Harvey WF, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967\u201375. https:\/\/doi.org\/10.1001\/jama.2017.5283.","journal-title":"JAMA"},{"key":"3994_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-024-03752-7","author":"MW Little","year":"2024","unstructured":"Little MW, O\u2019Grady A, Briggs J, et al. Genicular artery embolisation in patients with osteoarthritis of the knee (GENESIS) using permanent microspheres: long-term results. Cardiovasc Intervent Radiol. 2024. https:\/\/doi.org\/10.1007\/s00270-024-03752-7.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"3994_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jvir.2021.09.019","volume":"33","author":"S Bagla","year":"2022","unstructured":"Bagla S, Piechowiak R, Sajan A, Orlando J, Hartman T, Isaacson A. Multicenter randomized sham controlled study of genicular artery embolization for knee pain secondary to osteoarthritis. J Vasc Interv Radiol. 2022;33(1):2\u201310. https:\/\/doi.org\/10.1016\/j.jvir.2021.09.019.","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"3994_CR11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jvir.2019.09.018","volume":"31","author":"S Bagla","year":"2020","unstructured":"Bagla S, Piechowiak R, Hartman T, Orlando J, Del Gaizo D, Isaacson A. Genicular artery embolization for the treatment of knee pain secondary to osteoarthritis. J Vasc Interv Radiol. 2020;31(7):1096\u2013102. https:\/\/doi.org\/10.1016\/j.jvir.2019.09.018.","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"3994_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jvir.2017.02.033","volume":"28","author":"Y Okuno","year":"2017","unstructured":"Okuno Y, Korchi AM, Shinjo T, Kato S, Kaneko T. Midterm clinical outcomes and MR imaging changes after transcatheter arterial embolization as a treatment for mild to moderate radiographic knee osteoarthritis resistant to conservative treatment. J Vasc Interv Radiol. 2017;28(7):995\u20131002. https:\/\/doi.org\/10.1016\/j.jvir.2017.02.033.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"3994_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00270-014-0944-8","volume":"38","author":"Y Okuno","year":"2015","unstructured":"Okuno Y, Korchi AM, Shinjo T, Kato S. Transcatheter arterial embolization as a treatment for medial knee pain in patients with mild to moderate osteoarthritis. Cardiovasc Intervent Radiol. 2015;38(2):336\u201343. https:\/\/doi.org\/10.1007\/s00270-014-0944-8.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3994_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.knee.2022.12.008","volume":"41","author":"S Bhatia","year":"2023","unstructured":"Bhatia S, Jalaeian H, Kumar J, et al. Two-year outcomes comparing Embosphere(R) microspheres versus Imipenem Cilastatin for genicular artery embolization in patients with moderate to severe knee osteoarthritis. Knee. 2023;41:38\u201347. https:\/\/doi.org\/10.1016\/j.knee.2022.12.008.","journal-title":"Knee"},{"issue":"6","key":"3994_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00270-023-03422-0","volume":"46","author":"Y Epelboym","year":"2023","unstructured":"Epelboym Y, Mandell JC, Collins JE, et al. Genicular artery embolization as a treatment for osteoarthritis related knee pain: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2023;46(6):760\u20139. https:\/\/doi.org\/10.1007\/s00270-023-03422-0.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3994_CR16","doi-asserted-by":"publisher","unstructured":"Padia SA, Genshaft S, Blumstein G, et al. Genicular artery embolization for the treatment of symptomatic knee osteoarthritis. JB JS Open Access. 2021;6(4)https:\/\/doi.org\/10.2106\/JBJS.OA.21.00085","DOI":"10.2106\/JBJS.OA.21.00085"},{"key":"3994_CR17","doi-asserted-by":"publisher","unstructured":"Ahmed O, Epelboym Y, Haskal ZJ, et al. Society of interventional radiology research reporting standards for genicular artery embolization. J Vasc Interv Radiol. 27. 2024;https:\/\/doi.org\/10.1016\/j.jvir.2024.04.018","DOI":"10.1016\/j.jvir.2024.04.018"},{"issue":"1","key":"3994_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/rg.210159","volume":"42","author":"DB Heller","year":"2022","unstructured":"Heller DB, Beggin AE, Lam AH, Kohi MP, Heller MB. Geniculate artery embolization: role in knee hemarthrosis and osteoarthritis. Radiographics. 2022;42(1):289\u2013301. https:\/\/doi.org\/10.1148\/rg.210159.","journal-title":"Radiographics"},{"key":"3994_CR19","doi-asserted-by":"publisher","unstructured":"Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ. 10 2004;328(7444):869. https:\/\/doi.org\/10.1136\/bmj.38039.573970.7C","DOI":"10.1136\/bmj.38039.573970.7C"},{"issue":"5","key":"3994_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1590\/1413-785220172505172581","volume":"25","author":"AF Buyuk","year":"2017","unstructured":"Buyuk AF, Kilinc E, Camurcu IY, Camur S, Ucpunar H, Kara A. Compared efficacy of intra-articular injection of methylprednisolone and triamcinolone. Acta Ortop Bras. 2017;25(5):206\u20138. https:\/\/doi.org\/10.1590\/1413-785220172505172581.","journal-title":"Acta Ortop Bras"},{"issue":"2","key":"3994_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/art.10777","volume":"48","author":"JP Raynauld","year":"2003","unstructured":"Raynauld JP, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48(2):370\u20137. https:\/\/doi.org\/10.1002\/art.10777.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3994_CR22","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/s00270-019-02289-4","volume":"42","author":"SH Lee","year":"2019","unstructured":"Lee SH, Hwang JH, Kim DH, et al. Clinical outcomes of transcatheter arterial embolisation for chronic knee pain: mild-to-moderate versus severe knee osteoarthritis. Cardiovasc Intervent Radiol. 2019;42(11):1530\u20136. https:\/\/doi.org\/10.1007\/s00270-019-02289-4.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"3994_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00270-020-02764-3","volume":"44","author":"MW Little","year":"2021","unstructured":"Little MW, Gibson M, Briggs J, et al. Genicular artEry embolizatioN in patiEnts with oSteoarthrItiS of the knee (GENESIS) using permanent microspheres: interim analysis. Cardiovasc Intervent Radiol. 2021;44(6):931\u201340. https:\/\/doi.org\/10.1007\/s00270-020-02764-3.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"3994_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.jvir.2020.05.007","volume":"31","author":"S Landers","year":"2020","unstructured":"Landers S, Hely R, Page R, et al. Genicular artery embolization to improve pain and function in early-stage knee osteoarthritis-24-month pilot study results. J Vasc Interv Radiol. 2020;31(9):1453\u20138. https:\/\/doi.org\/10.1016\/j.jvir.2020.05.007.","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"3994_CR25","doi-asserted-by":"publisher","first-page":"e087047","DOI":"10.1136\/bmjopen-2024-087047","volume":"14","author":"TA van Zadelhoff","year":"2024","unstructured":"van Zadelhoff TA, Bos PK, Moelker A, Bierma-Zeinstra SMA, van der Heijden RA, Oei EHG. Genicular artery embolisation versus sham embolisation for symptomatic osteoarthritis of the knee: a randomised controlled trial. BMJ Open. 2024;14(10):e087047. https:\/\/doi.org\/10.1136\/bmjopen-2024-087047.","journal-title":"BMJ Open"},{"key":"3994_CR26","doi-asserted-by":"publisher","unstructured":"Correa MP, Motta-Leal-Filho JM, Lugokeski R, Mezzomo M, Leite LR. GAUCHO - trial genicular artery embolization using imipenem\/cilastatin vs. microsphere for knee osteoarthritis: a randomized controlled trial. Cardiovasc Intervent Radiol. 2022;45(7):903\u2013910. https:\/\/doi.org\/10.1007\/s00270-022-03089-z","DOI":"10.1007\/s00270-022-03089-z"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-03994-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-025-03994-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-03994-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:55:16Z","timestamp":1743569716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-025-03994-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3994"],"URL":"https:\/\/doi.org\/10.1007\/s00270-025-03994-z","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CB: Lecturer for Merit Medical Systems, Inc. SB: Consultancy and clinical research for Merit Medical Systems, Inc.; educational grant from Asahi Medical; consultant and clinical research for Terumo; consultant and clinical research for Crannmed; clinical research for Guerbet. CJM: Nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethics approval has been granted by local ethics committees for each center participating in the study (Protocol no.: GAE-P3-22-01, version 2, February 16, 2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Participants"}},{"value":"Informed consent will be obtained from all patients included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}